On September 12, Sanofi announced that it withdrew the FDA application for its once-daily GLP-1 agonist lixisenatide... Continue Reading »
- Understanding Diabetes
- Living with Diabetes
- The Latest
The latest research in type 1 diabetes, type 2 diabetes, prediabetes, and beyond. Here you’ll find information on experimental therapies, new data and results, and scientific findings.